Carsten Terjung

This inventor holds 13 USPTO granted patents and 13 published patent applications and 6 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Johns Hopkins University. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Terjung. Retrieved from https://idiyas.com/inventor/carsten-terjung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 13)

% Patents Active = 69.2

EPO Patents = 6 (Patent Applications = 21)

Average Co-Inventor Count = 10.9

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

12 out of 387

Bayer Pharma Aktiengesellschaft

patents

4 out of 12,268

Bayer Aktiengesellschaft

patents

1 out of 3,803

Johns Hopkins University

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612399 - Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof (2026-04-28),

2. 12144865 - Antibody drug conjugates with enzymatically cleavable groups (2024-11-19),

3. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups (2023-06-27),

4. 11667675 - MASP inhibitory compounds and uses thereof (2023-06-06),

5. 11337973 - Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors (2022-05-24),

6. 11136296 - Substituted-arylethyl-2-arylquinoline-4-carboxamides and use thereof (2021-10-05),

7. 11123439 - Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups (2021-09-21),

8. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof (2020-07-28),

9. 10485880 - Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies (2019-11-26),

10. 10479765 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-11-19),

11. 10189788 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-01-29),

12. 10117864 - Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof (2018-11-06),

13. 10022453 - Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) (2018-07-17),

Title: Carsten Terjung - Innovative Inventor from Bochum

Introduction: Carsten Terjung is a renowned inventor hailing from Bochum, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Carsten Terjung holds several patents in the areas of renewable energy, sustainable transportation, and smart city solutions, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in the tech industry, Carsten Terjung has worked with leading companies to develop cutting-edge technologies that have revolutionized various sectors.

Collaborations: Throughout his career, Carsten Terjung has collaborated with top research institutions and universities to further his innovative projects, demonstrating his dedication to pushing the boundaries of technology.

Conclusion: Carsten Terjung's passion for innovation and his relentless pursuit of technological advancement make him a standout figure in the world of inventors, inspiring the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.